ArticleMolecular and clinical oncology2014

Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth.

Akinori Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.